China Resources Boya Bio-pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001FF1
CNY
23.69
-3.98 (-14.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
467.01
530.63
484.27
344.43
443.28
444.44
457.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
467.01
530.63
484.27
344.43
443.28
444.44
457.20
Raw Material Cost
246.58
268.13
214.59
136.11
163.33
156.89
172.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.36
0.09
0.54
0.02
0.09
0.02
0.04
Selling and Distribution Expenses
141.31
138.05
194.00
109.93
124.15
132.28
152.49
Other Expenses
1.11
0.94
1.78
1.59
1.02
1.80
1.85
Total Expenditure (Excl Depreciation)
399.39
415.63
426.98
261.96
297.77
307.14
343.25
Operating Profit (PBDIT) excl Other Income
67.6
115
57.300000000000004
82.5
145.5
137.3
114
Other Income
20.67
23.94
20.22
7.57
26.44
19.82
-15.70
Operating Profit (PBDIT)
130.58
181.06
25.39
123.19
197.22
183.91
-202.54
Interest
0.36
0.09
0.54
0.02
0.09
0.02
0.04
Exceptional Items
12.27
24.74
4.77
21.73
20.57
18.52
10.02
Gross Profit (PBDT)
220.43
262.50
269.68
208.32
279.95
287.55
284.97
Depreciation
42.35
42.35
32.32
32.32
26.13
26.13
28.93
Profit Before Tax
100.13
163.35
-2.71
112.58
191.58
176.27
-221.49
Tax
14.02
24.06
13.19
15.85
27.63
24.51
4.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
85.86
139.48
-15.71
96.73
163.95
152.02
-226.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
85.86
139.48
-15.71
96.73
163.95
152.02
-226.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.26
-0.19
-0.19
-0.00
-0.00
-0.26
0.66
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
86.12
139.29
-15.90
96.73
163.94
151.76
-225.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,628.47
7,626.26
7,487.15
7,581.18
7,484.45
7,471.78
7,319.75
Earnings per share (EPS)
0.17
0.28
-0.03
0.19
0.33
0.3
-0.45
Diluted Earnings per share
0.17
0.28
-0.03
0.19
0.33
0.3
-0.45
Operating Profit Margin (Excl OI)
14.47%
21.63%
-5.61%
24.18%
32.63%
31.04%
-47.19%
Gross Profit Margin
30.51%
38.77%
6.11%
42.07%
49.11%
45.54%
-42.12%
PAT Margin
18.38%
26.29%
-3.24%
28.08%
36.98%
34.21%
-49.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -11.99% vs 9.56% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -38.19% vs 976.10% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -30.04% vs 2,921.15% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 300.00% vs -80.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of China Resources Boya Bio-pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
467.01
0
467.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
467.01
0
467.01
Raw Material Cost
246.58
0
246.58
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.36
0
0.36
Selling and Distribution Expenses
141.31
0
141.31
Other Expenses
1.11
0.00
1.11
Total Expenditure (Excl Depreciation)
399.39
0
399.39
Operating Profit (PBDIT) excl Other Income
67.62
0.00
67.62
Other Income
20.67
0
20.67
Operating Profit (PBDIT)
130.58
0
130.58
Interest
0.36
0
0.36
Exceptional Items
12.27
0
12.27
Gross Profit (PBDT)
220.43
0
220.43
Depreciation
42.35
0
42.35
Profit Before Tax
100.13
0
100.13
Tax
14.02
0
14.02
Provisions and contingencies
0
0
0.00
Profit After Tax
85.86
0
85.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
85.86
0
85.86
Share in Profit of Associates
0
0
0.00
Minority Interest
0.26
0
0.26
Other related items
0.00
0.00
0.00
Consolidated Net Profit
86.12
0
86.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,628.47
0
7,628.47
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
14.47%
0%
0.00
14.47%
Gross Profit Margin
30.51%
0%
0.00
30.51%
PAT Margin
18.38%
0%
0.00
18.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 46.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -11.99% vs 9.56% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 5.35% vs -39.27% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.61 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -38.19% vs 976.10% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -47.47% vs 3.54% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.99 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -30.04% vs 2,921.15% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -35.66% vs 3.33% in Jun 2024

Quarterly - Interest
Interest 0.04 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 300.00% vs -80.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 300.00% vs -50.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.47%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024